HB1316 Summary

• Amends Hawaii Revised Statutes Section 329-38(f) to allow qualified individual practitioners to prescribe Schedule III, IV, or V narcotic drugs for detoxification or maintenance treatment of narcotic drug-dependent persons.

• Requires practitioners to comply with federal requirements under title 21 United States Code section 823(g) and title 21 Code of Federal Regulations section 1301.28.

• Permits prescription of FDA-approved Schedule III, IV, or V narcotic drugs (such as buprenorphine) for detoxification and maintenance treatment, aligning Hawaii law with federal regulations.

• Corrects technical references from "Drug Enforcement Agency" to "Drug Enforcement Administration" and updates regulatory citations from Title 21 Code of Federal Regulations to title 21 United States Code.

• Takes effect on July 1, 2017.